Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study
GOY, Andre, SINHA, Rajni, WILLIAMS, Michael E, BESISIK, Sevgi Kalayoglu, DRACH, Johannes, RAMCHANDREN, Radhakrishnan, LEI ZHANG, CICERO, Sherri, FU, Tommy, WITZIG, Thomas E
Published in Journal of clinical oncology (10.10.2013)
Published in Journal of clinical oncology (10.10.2013)
Get full text
Journal Article
Longer‐term follow‐up and outcome by tumour cell proliferation rate (Ki‐67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL‐001(EMERGE) pivotal trial
Goy, Andre, Kalayoglu Besisik, Sevgi, Drach, Johannes, Ramchandren, Radhakrishnan, Robertson, Michael J., Avivi, Irit, Rowe, Jacob M., Herbrecht, Raoul, Van Hoof, Achiel, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Witzig, Thomas
Published in British journal of haematology (01.08.2015)
Published in British journal of haematology (01.08.2015)
Get full text
Journal Article
P3‐018: An Evaluation of the Safety of Nelotanserin, A Highly Potent and Selective 5‐HT2A Inverse Agonist That is Being Developed as a Treatment for Visual Hallucinations and REM Behavior Disorder in Lewy Body Dementia
Wen, Warren, Ramaswamy, Shankar, Piscitelli, Stephen C., Cicero, Sherri, Lynch, Shau Yu, Friedhoff, Lawrence
Published in Alzheimer's & dementia (01.07.2016)
Published in Alzheimer's & dementia (01.07.2016)
Get full text
Journal Article
AN EVALUATION OF THE SAFETY OF NELOTANSERIN, A HIGHLY POTENT AND SELECTIVE 5-HT2A INVERSE AGONIST THAT IS BEING DEVELOPED AS A TREATMENT FOR VISUAL HALLUCINATIONS AND REM BEHAVIOR DISORDER IN LEWY BODY DEMENTIA
Wen, Warren, Ramaswamy, Shankar, Piscitelli, Stephen C, Cicero, Sherri, Lynch, Shau Yu, Friedhoff, Lawrence
Published in Alzheimer's & dementia (01.07.2016)
Published in Alzheimer's & dementia (01.07.2016)
Get full text
Journal Article
Lenalidomide in relapsed/refractory mantle cell lymphoma post-bortezomib: Subgroup analysis of the MCL-001 study
Williams, Michael E., Goy, Andre, Sinha, Rajni, Kalayoglu Besisik, Sevgi, Drach, Johannes W., Ramchandren, Rod, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Witzig, Thomas E
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Combined analysis of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma
Witzig, Thomas E., Vose, Julie, Zinzani, Pier Luigi, Habermann, Thomas Matthew, Tuscano, Joseph M., Sinha, Rajni, Williams, Michael E., Drach, Johannes W., Ramchandren, Rod, Kalayoglu Besisik, Sevgi, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Goy, Andre
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study
Goy, Andre, Sinha, Rajni, Williams, Michael E., Besisik, Sevgi Kalayoglu, Drach, Johannes, Ramchandren, Radhakrishnan, Robertson, Michael J., Avivi, Irit, Rowe, Jacob M., Herbrecht, Raoul, Van Hoof, Achiel, Egyed, Miklos, Zhang, Lei, Cicero, Sherri, Fu, Tommy, Witzig, Thomas E.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article